
Tadalafil (Cialis)
Tadalafil is an FDA-approved PDE5 inhibitor with strong trial evidence for erectile dysfunction (Cialis label), for urinary symptoms of an enlarged prostate (Cialis label) and for exercise ability in pulmonary arterial hypertension (Adcirca label). The biggest safety rule is never to combine it with nitrates or riociguat. Concentrated beetroot products, which supply dietary nitrate, are rated a moderate interaction in our database because both lower blood pressure, although no study has tested beetroot together with tadalafil.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Men with erectile dysfunction or BPH symptoms (Cialis), and adults with pulmonary arterial hypertension (Adcirca), whose prescriber recommends it
Common dosing range
Set by your prescriber and depends on the label: Cialis for ED 10 mg as needed (5 to 20 mg) or 2.5 to 5 mg once daily; Cialis for BPH 5 mg once daily; Adcirca for PAH 40 mg (two 20 mg tablets) once daily
When to expect effects
For ED, the Cialis label says it improved erections compared with placebo for up to 36 hours after a dose; for BPH, symptom scores improved by 4 weeks in trials; for PAH, walking distance improved by 8 weeks
Watch out for
Never take it with nitrate medicines (such as nitroglycerin or isosorbide) or "poppers", or with riociguat: blood pressure can drop dangerously. Alpha-blockers, blood pressure medicines and heavy drinking (5 or more units) add to the drop. Seek emergency care for an erection lasting more than 4 hours, sudden vision loss or sudden hearing loss
What is it
Tadalafil is a prescription PDE5 inhibitor taken by mouth. It has two US labels. The Cialis label (Eli Lilly; 5, 10 and 20 mg tablets) approves it for erectile dysfunction (ED), for the signs and symptoms of benign prostatic hyperplasia (BPH, an enlarged prostate), and for both together. The Adcirca label (United Therapeutics; 20 mg tablets) approves it for pulmonary arterial hypertension (PAH, WHO Group 1) to improve exercise ability. Generic tadalafil tablets are also sold. Both labels list the same key contraindications: it must not be combined with nitrate medicines or with guanylate cyclase stimulators such as riociguat.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
erectile dysfunction (Cialis label) Strong Evidence | Large; 81% versus 35% reported improved erections | Adult men with erectile dysfunction of most causes, including diabetes | Effect within the dosing window; trials lasted 12 weeks |
urinary symptoms of benign prostatic hyperplasia (Cialis label) Good Evidence | Moderate; about 2.6 points more symptom improvement than placebo on 5 mg | Men with BPH urinary symptoms, especially those who also have erectile dysfunction | Improvement by 4 weeks |
peak urine flow in benign prostatic hyperplasia Good Evidence | No difference from placebo | Men with BPH urinary symptoms | Measured at 12 weeks |
exercise ability in pulmonary arterial hypertension (Adcirca label) Good Evidence | Moderate; about 33 meters more walking distance than placebo | Adults with WHO Group 1 PAH and functional class II to III symptoms | Walking distance improved by 8 weeks |
starting treatment for pulmonary arterial hypertension with ambrisentan Good Evidence | Large; about half the risk of clinical failure versus either drug alone | Adults newly diagnosed with WHO Group 1 PAH whose specialist considers combination therapy | Event-driven trial measuring time to first clinical failure |
erectile dysfunction (Cialis label)
- Effect
- Large; 81% versus 35% reported improved erections
- Best fit
- Adult men with erectile dysfunction of most causes, including diabetes
- Time
- Effect within the dosing window; trials lasted 12 weeks
urinary symptoms of benign prostatic hyperplasia (Cialis label)
- Effect
- Moderate; about 2.6 points more symptom improvement than placebo on 5 mg
- Best fit
- Men with BPH urinary symptoms, especially those who also have erectile dysfunction
- Time
- Improvement by 4 weeks
peak urine flow in benign prostatic hyperplasia
- Effect
- No difference from placebo
- Best fit
- Men with BPH urinary symptoms
- Time
- Measured at 12 weeks
exercise ability in pulmonary arterial hypertension (Adcirca label)
- Effect
- Moderate; about 33 meters more walking distance than placebo
- Best fit
- Adults with WHO Group 1 PAH and functional class II to III symptoms
- Time
- Walking distance improved by 8 weeks
starting treatment for pulmonary arterial hypertension with ambrisentan
- Effect
- Large; about half the risk of clinical failure versus either drug alone
- Best fit
- Adults newly diagnosed with WHO Group 1 PAH whose specialist considers combination therapy
- Time
- Event-driven trial measuring time to first clinical failure
Evidence for 5 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
erectile dysfunction (Cialis label)
Disease adjunctAn integrated analysis of 5 double-blind, placebo-controlled 12-week trials included 1,112 men (mean age 59, range 22 to 82) with mild to severe erectile dysfunction of various causes, taking tadalafil as needed without food or alcohol limits. On 20 mg, the erectile function score improved by 7.9 points, 75% of intercourse attempts were completed successfully, and 81% reported improved erections at the end versus 35% on placebo. Benefit was seen across severities, causes and ages. Headache and indigestion were the most common side effects. The Cialis label also lists once-daily 2.5 and 5 mg dosing, tested in separate trials.
Bottom line: As-needed tadalafil clearly improves erections in men with erectile dysfunction.
urinary symptoms of benign prostatic hyperplasia (Cialis label)
Disease adjunctIn a double-blind dose-finding trial, 1,058 men with urinary symptoms from BPH took placebo or tadalafil 2.5, 5, 10 or 20 mg once daily for 12 weeks. The International Prostate Symptom Score improved by 4.9 points on 5 mg versus 2.3 on placebo, with improvement seen at 4, 8 and 12 weeks. Peak urine flow did not improve at any dose. The authors wrote that, of the doses studied, 5 mg appeared to provide a positive risk-benefit profile; 5 mg is the dose the Cialis label uses for BPH.
Bottom line: Daily tadalafil 5 mg modestly eases urinary symptoms of an enlarged prostate.
peak urine flow in benign prostatic hyperplasia
No benefit foundIn the same 12-week trial of 1,058 men with BPH symptoms, peak urine flow was measured, and no tadalafil dose (2.5 to 20 mg daily) improved it compared with placebo, even though symptom scores improved.
Bottom line: Tadalafil eased BPH symptoms but did not improve how fast urine flows.
exercise ability in pulmonary arterial hypertension (Adcirca label)
Disease adjunctIn the double-blind 16-week PHIRST trial, 405 people with pulmonary arterial hypertension (idiopathic or associated with other conditions), either untreated or already on bosentan, took placebo or tadalafil 2.5, 10, 20 or 40 mg once daily. The Adcirca label, which describes this trial, says 61% had idiopathic or heritable PAH, 23% PAH linked to connective tissue disease, and 53% were taking bosentan. Only 40 mg met the planned test: it increased 6-minute walking distance by 33 meters more than placebo (44 meters in people not on bosentan, 23 meters in those on it). It also delayed clinical worsening and improved quality of life, but WHO functional class did not change significantly. Headache, muscle pain and flushing were the most common side effects.
Bottom line: Tadalafil 40 mg once daily modestly improves walking distance and delays worsening in PAH.
starting treatment for pulmonary arterial hypertension with ambrisentan
Disease adjunctIn the double-blind AMBITION trial, 500 previously untreated people with PAH (functional class II or III) took ambrisentan 10 mg plus tadalafil 40 mg, or either drug alone. Clinical failure (death, hospitalization for worsening PAH, disease progression or an unsatisfactory long-term response) occurred in 18% on the combination versus 34% on ambrisentan alone and 28% on tadalafil alone (31% for the two single-drug groups combined; hazard ratio 0.50 versus that combined group). Swelling of the legs, headache, nasal congestion and anemia were more frequent with the combination. The trial was funded by Gilead Sciences and GlaxoSmithKline.
Bottom line: Starting tadalafil together with ambrisentan halved clinical failure compared with either drug alone.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose for your condition; never combine it with nitrates or riociguat, and tell every doctor you take it.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Neither the Cialis nor the Adcirca label has a boxed warning. Both labels contraindicate use with any organic nitrate and with guanylate cyclase stimulators such as riociguat, because the blood pressure drop can be dangerous. The Cialis label says that if a nitrate is needed in a life-threatening situation, at least 48 hours should pass after the last tadalafil dose, under close medical monitoring.
Heart events: serious cardiovascular events, including heart attack, sudden cardiac death and stroke, have been reported after use, mostly in people with existing risk factors, often during or shortly after sex. The Cialis label says not to use it when sexual activity is inadvisable because of heart status.
Sudden vision loss from NAION (an optic nerve stroke), reported rarely with all PDE5 inhibitors; two observational studies suggested about a 2-fold higher risk soon after use, without proving cause. Sudden hearing loss has also been reported. Both labels say to stop and seek care.
Erections lasting more than 4 hours and priapism, which can permanently damage the penis if not treated quickly; low blood pressure; and, for Adcirca, possible worsening in pulmonary veno-occlusive disease. Serious skin reactions, including Stevens-Johnson syndrome, have been reported.
Who should avoid it
- People who use any nitrate medicine (nitroglycerin, isosorbide dinitrate or mononitrate) or nitrate "poppers", or a guanylate cyclase stimulator such as riociguat (contraindicated on both labels)
- People with a known serious allergy to tadalafil, Cialis or Adcirca (contraindicated)
- Cialis label: people who in recent months had a heart attack (90 days), stroke (6 months), unstable angina, heart failure of class 2 or higher (6 months), uncontrolled arrhythmia, low blood pressure below 90/50 or uncontrolled high blood pressure (not recommended), and people with retinitis pigmentosa
- People with severe liver impairment, or with severe kidney impairment for daily use (Cialis) or for Adcirca; and anyone taking another PDE5 inhibitor, including Cialis together with Adcirca
Pregnancy & breastfeeding
Pregnancy: the Cialis label says Cialis is not indicated for use in females and that there are no data on its use in pregnant women. The Adcirca label, used for PAH in women as well as men, says limited data from case series have not identified a drug-associated risk of major birth defects, miscarriage or other harm to mother or baby, and that untreated PAH in pregnancy carries a risk of heart failure, stroke, preterm delivery and maternal and fetal death. Animal studies showed no birth defects at several times the human dose. Breastfeeding: there is no information on tadalafil in human milk; it was found in rat milk at about 2.4 times plasma levels, and the Adcirca label says to weigh the benefits of breastfeeding against the mother's need for treatment and possible effects on the child. Fertility: in two of three studies in men, tadalafil lowered sperm concentration, with unknown clinical significance.
Interactions
Both labels contraindicate this combination because tadalafil greatly increases the blood-pressure-lowering effect of nitrates. Never combine them. If you get chest pain after taking tadalafil, seek emergency care and tell the team when you took it; the Cialis label says at least 48 hours should pass before a nitrate is considered.
Both labels contraindicate this combination because tadalafil may increase the blood-pressure-lowering effect of these medicines, which are also used for pulmonary hypertension. Make sure your lung or heart specialist knows about every tadalafil prescription.
Both are blood vessel relaxers, so blood pressure can drop and cause fainting. The Cialis label says men taking an alpha-blocker should be stable on it before starting tadalafil for ED at the lowest dose, and that the combination is not recommended for treating BPH. Other blood pressure medicines caused only small extra drops in studies. Your prescriber decides.
Ketoconazole 400 mg a day raised tadalafil exposure by 312%. The Cialis label limits as-needed use to 10 mg no more than once every 72 hours and daily use to 2.5 mg with these medicines; the Adcirca label says to avoid ketoconazole and itraconazole and gives a special plan for ritonavir. The Cialis label adds that erythromycin would likely raise levels too, although this was not specifically studied.
Rifampin lowered tadalafil exposure by 88%, which can be expected to make daily tadalafil work less well. The Adcirca label says to avoid tadalafil for PAH in people taking strong inducers such as rifampin long term. Ask your prescriber before starting one of these.
Beetroot is rich in dietary nitrate, which the body turns into nitric oxide. A 2013 meta-analysis of 16 small crossover trials (254 adults, each lasting 2 hours to 15 days) found beetroot juice and inorganic nitrate supplements lowered systolic blood pressure by about 4.4 mm Hg; it did not study tadalafil. Tadalafil prolongs the same nitric oxide signal and also lowers blood pressure a little, so concentrated products may add to that effect. No study has tested beetroot together with tadalafil, and the trials used juice and supplements, not beets eaten in meals. Ask your doctor or pharmacist about regular beetroot shots or nitrate pre-workout products, especially if you take tadalafil for PAH or feel lightheaded on standing.
Alcohol and tadalafil both relax blood vessels, so together they can lower blood pressure more. In studies on the Cialis label, a large amount of alcohol drunk quickly with tadalafil caused more blood pressure drops than alcohol alone, and some people had dizziness or a fall in blood pressure on standing; a smaller amount did not. The labels warn that 5 or more drinks can cause dizziness, a faster heartbeat and headache. Keep drinking moderate and stand up slowly, especially if you also take blood pressure medicines.
Tadalafil is cleared mainly by CYP3A4, which grapefruit juice blocks. Both labels say grapefruit juice would likely raise tadalafil levels, though this has not been studied in people; a rat study found 75% higher peak levels. Higher levels may mean more headache, flushing and dizziness. It is safest to avoid grapefruit, especially with daily tadalafil.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take beetroot juice or nitrate supplements with tadalafil?⌄
Our database rates concentrated beetroot products a moderate interaction. Dietary nitrate lowers blood pressure a little through the same nitric oxide pathway that tadalafil prolongs, so the effects may add up. No study has tested beetroot together with tadalafil, and the blood pressure trials used beetroot juice and nitrate supplements, not beets eaten in meals. Ask your doctor or pharmacist before using beetroot shots or nitrate pre-workout products, especially if you take tadalafil for PAH.
Are "natural" ED supplements safer than tadalafil?⌄
Not necessarily. The FDA warns that many products sold for sexual enhancement or erectile dysfunction, sometimes advertised as dietary supplements or all-natural treatments, are likely to be contaminated with dangerous hidden ingredients, and that its public list covers only a small fraction of them. Show any such product to your doctor or pharmacist before using it with tadalafil.
Can I drink alcohol with tadalafil?⌄
Both labels say alcohol and tadalafil each widen blood vessels, and 5 or more units of alcohol with tadalafil can cause dizziness, a faster heartbeat, headache and a drop in blood pressure on standing. Ask your prescriber what amount is reasonable for you.
Is grapefruit a problem with tadalafil?⌄
The Cialis label says grapefruit juice would likely increase tadalafil levels because it blocks the CYP3A4 enzyme, although this was not specifically studied. Ask your pharmacist whether you should avoid grapefruit juice with your dose.
Why does the same drug have two brand names?⌄
Cialis is the tadalafil label for erectile dysfunction and enlarged prostate symptoms, and Adcirca is the label for pulmonary arterial hypertension, at a higher daily dose of 40 mg. Both labels say not to combine them or take another PDE5 inhibitor such as sildenafil.
What if I need nitroglycerin for chest pain?⌄
Nitrates and tadalafil must not be combined. If you have chest pain after taking tadalafil, call emergency services and tell them you took tadalafil and when. The Cialis label says that if a nitrate is medically necessary, at least 48 hours should pass after the last dose, with close monitoring.
References by claim
erectile dysfunction (Cialis label)
Brock et al., 2002 · PubMed (2002) link
urinary symptoms of benign prostatic hyperplasia (Cialis label)
Roehrborn et al., 2008 · PubMed (2008) link
exercise ability in pulmonary arterial hypertension (Adcirca label)
Galiè et al., 2009 · PubMed (2009) link
starting treatment for pulmonary arterial hypertension with ambrisentan
Galiè et al., 2015 · PubMed (2015) link
Safety
Interaction: Beetroot (concentrated juice, powders and nitrate supplements)
Siervo et al., 2013 · PubMed (2013) link
Interaction: Grapefruit and grapefruit juice
Shen et al., 2020 · PMC (2020) link
Track Tadalafil (Cialis) with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
